Ardelyx reported $5.57M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Amgen USD 5.91B 2.31B Sep/2025
Ardelyx USD 5.57M 17.44M Sep/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Sanofi EUR 5.66B 3.77B Sep/2025
TG Therapeutics USD 37.7M 25.41M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025